Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

γ-Aminobutyric Acid Receptor Binding in Mammalian Brain

Heterogeneity of Binding Sites

RICHARD W. OLSEN, MARK O. BERGMAN, PAUL C. VAN NESS, SARAH C. LUMMIS, ANDREW E. WATKINS, CHRISTIAN NAPIAS and DONALD V. GREENLEE
Molecular Pharmacology March 1981, 19 (2) 217-227;
RICHARD W. OLSEN
Division of Biomedical Sciences and Department of Biochemistry, University of California, Riverside, California 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARK O. BERGMAN
Division of Biomedical Sciences and Department of Biochemistry, University of California, Riverside, California 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAUL C. VAN NESS
Division of Biomedical Sciences and Department of Biochemistry, University of California, Riverside, California 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SARAH C. LUMMIS
Division of Biomedical Sciences and Department of Biochemistry, University of California, Riverside, California 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREW E. WATKINS
Division of Biomedical Sciences and Department of Biochemistry, University of California, Riverside, California 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTIAN NAPIAS
Division of Biomedical Sciences and Department of Biochemistry, University of California, Riverside, California 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DONALD V. GREENLEE
Division of Biomedical Sciences and Department of Biochemistry, University of California, Riverside, California 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The binding of radioactive γ-aminobutyric acid (GABA) to receptor-like sites in mammalian brain membranes was analyzed by computer for comparison with models which might explain the observed apparent heterogeneity of ligand binding. The best fit was obtained with two independent binding sites. Binding was measured by centrifugation, using thoroughly washed, frozen, and thawed membranes without detergent treatment. Assays were carried out at 0° under sodium ion-free conditions which have previously been shown to allow detection only of those binding sites having the chemical specificity and other properties expected of receptor sites for the neurotransmitter GABA. Quantitative analysis of binding curves for several brain regions, subcellular fractions, and species revealed the general presence of two affinity classes for GABA receptors, one with KD Of 13 ± 6 nM (Bmax = 0.33 pmole/mg of protein in bovine cortex) and the other with KD of 300 ± 150 nM (Bmax 1.8 pmole/mg of protein in bovine cortex). The two-site model fit the data better than did models with one site, three sites, or negative cooperativity, but the fit to the mobile receptor-effector coupling hypothesis was almost as good as that of the two-site model. Consistent with the heterogeneity in equilibrium binding data, heterogeneity was also observed for association and dissociation rates of ligand binding and for rates of thermal inactivation of binding activity. The rate of heat denaturation was biphasic, with earlier times corresponding to selective loss of one of the two binding affinity subpopulations. Kinetics studies revealed two subpopulations of binding sites with respect to on- and off-rates. A slow component with k+1 = 1.9 x 107 M-1 min-1, and k-1 = 0.2 min-1, KD = 11 nM, and low Bmax corresponded to the high-affinity component of the equilibrium binding curve, and a rapidly dissociating population with lower affinity and higher Bmax corresponded to the lower-affinity component of the equilibrium binding curve. Independent IC50 values for the high-affinity and low-GABA site were determined for a series of analogues. All analogues tested were more effective inhibitors of the high-affinity GABA sites, and a marked similarity in the relative drug potency for the two sites was observed. Thus the heterogeneity of GABA binding would appear to involve two discrete populations of receptors on the grounds of noninterconvertible heterogeneity under the conditions tested, whereas the similarity in the drug specificity of the two populations would be more consistent with a model involving multiple coupled or conformational states of a single receptor.

ACKNOWLEDGMENTS We thank N. Birdsall, E. Hulme, B. Meiners, W. B. Levy, and D. Ching for helpful discussions, and A. Snowman for expert technical assistance.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 19, Issue 2
1 Mar 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
γ-Aminobutyric Acid Receptor Binding in Mammalian Brain
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

γ-Aminobutyric Acid Receptor Binding in Mammalian Brain

RICHARD W. OLSEN, MARK O. BERGMAN, PAUL C. VAN NESS, SARAH C. LUMMIS, ANDREW E. WATKINS, CHRISTIAN NAPIAS and DONALD V. GREENLEE
Molecular Pharmacology March 1, 1981, 19 (2) 217-227;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

γ-Aminobutyric Acid Receptor Binding in Mammalian Brain

RICHARD W. OLSEN, MARK O. BERGMAN, PAUL C. VAN NESS, SARAH C. LUMMIS, ANDREW E. WATKINS, CHRISTIAN NAPIAS and DONALD V. GREENLEE
Molecular Pharmacology March 1, 1981, 19 (2) 217-227;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Action of Org 34167 on HCN channels
  • The effects of echinocystic acid on Kv7 channels
  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics